Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Sparano

Showing results (71-80 of 293) with videos related to

Pageof 30
Sort By:
Cancer Research|August 1, 1993
Phase I trial of cyclophosphamide, doxorubicin, and 5-fluorouracil plus interferon-alpha 2b in patients with advanced breast cancerJ A Sparano, S Wadler, L Liebes, et al.
Oncotarget|January 10, 2018
The AKT inhibitor triciribine in combination with paclitaxel has order-specific efficacy against Zfp217-induced breast cancer chemoresistanceChristopher D Suarez, Junmin Wu, Sunil S Badve, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 11, 2020
Development and Validation of a Tool Integrating the 21-Gene Recurrence Score and Clinical-Pathological Features to Individualize Prognosis and Prediction of Chemotherapy Benefit in Early Breast CancerJoseph A Sparano, Michael R Crager, Gong Tang, et al.
NPJ Breast Cancer|December 14, 2023
Optimal adjuvant therapy in older (≥70 years of age) women with low-risk early-stage breast cancerM Chadha, J White, S M Swain, et al.
Breast Cancer Research and Treatment|October 19, 2011
GRB7 is required for triple-negative breast cancer cell invasion and survivalOrsi Giricz, Verónica Calvo, Stephanie C Pero, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|January 3, 2006
Cardiac asystole during right frontal lobe seizures: a case reportA Mascia, P P Quarato, A Sparano, et al.
Transfusion|March 1, 1992
Experience with autologous bone marrow harvesting and transfusion of marrow-derived red cellsN Ciobanu, V Weinberg, J A Sparano, et al.
Medical Oncology (Northwood, London, England)|August 20, 2005
Phase I trial of infusional cyclophosphamide, doxorubicin, and etoposide plus granulocyte-macrophage colony stimulating factor (GM-CSF) in non-Hodgkin's lymphomaJoseph A Sparano, Abdissa Negassa, Erick Lansigan, et al.
Clinical Breast Cancer|April 6, 2006
Plasma matrix metalloproteinases 7 and 9 in patients with metastatic breast cancer treated with marimastat or placebo: Eastern Cooperative Oncology Group trial E2196Stanley Zucker, Molin Wang, Joseph A Sparano, et al.
American Journal of Clinical Oncology|September 10, 2009
A phase I trial of oblimersen sodium in combination with cisplatin and 5-fluorouracil in patients with advanced esophageal, gastroesophageal junction, and gastric carcinomaRachel Raab, Joseph A Sparano, Allyson J Ocean, et al.
Pageof 30

Showing results (71-80 of 293) with videos related to

Sort By:
Pageof 30
Cancer Research|August 1, 1993
Phase I trial of cyclophosphamide, doxorubicin, and 5-fluorouracil plus interferon-alpha 2b in patients with advanced breast cancerJ A Sparano, S Wadler, L Liebes, et al.
Oncotarget|January 10, 2018
The AKT inhibitor triciribine in combination with paclitaxel has order-specific efficacy against Zfp217-induced breast cancer chemoresistanceChristopher D Suarez, Junmin Wu, Sunil S Badve, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 11, 2020
Development and Validation of a Tool Integrating the 21-Gene Recurrence Score and Clinical-Pathological Features to Individualize Prognosis and Prediction of Chemotherapy Benefit in Early Breast CancerJoseph A Sparano, Michael R Crager, Gong Tang, et al.
NPJ Breast Cancer|December 14, 2023
Optimal adjuvant therapy in older (≥70 years of age) women with low-risk early-stage breast cancerM Chadha, J White, S M Swain, et al.
Breast Cancer Research and Treatment|October 19, 2011
GRB7 is required for triple-negative breast cancer cell invasion and survivalOrsi Giricz, Verónica Calvo, Stephanie C Pero, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|January 3, 2006
Cardiac asystole during right frontal lobe seizures: a case reportA Mascia, P P Quarato, A Sparano, et al.
Transfusion|March 1, 1992
Experience with autologous bone marrow harvesting and transfusion of marrow-derived red cellsN Ciobanu, V Weinberg, J A Sparano, et al.
Medical Oncology (Northwood, London, England)|August 20, 2005
Phase I trial of infusional cyclophosphamide, doxorubicin, and etoposide plus granulocyte-macrophage colony stimulating factor (GM-CSF) in non-Hodgkin's lymphomaJoseph A Sparano, Abdissa Negassa, Erick Lansigan, et al.
Clinical Breast Cancer|April 6, 2006
Plasma matrix metalloproteinases 7 and 9 in patients with metastatic breast cancer treated with marimastat or placebo: Eastern Cooperative Oncology Group trial E2196Stanley Zucker, Molin Wang, Joseph A Sparano, et al.
American Journal of Clinical Oncology|September 10, 2009
A phase I trial of oblimersen sodium in combination with cisplatin and 5-fluorouracil in patients with advanced esophageal, gastroesophageal junction, and gastric carcinomaRachel Raab, Joseph A Sparano, Allyson J Ocean, et al.
Pageof 30